Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonlicromanol Extension Study in m.3243A>G Mitochondrial Disease
NCT04604548Phase 2Completed
- Sponsor
- Khondrion
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of sonlicromanol in mitochondrial disease, sponsored by Khondrion. Started Aug 2021; status: completed.
02
Drugs
sonlicromanol
03
Conditions
mitochondrial disease
Beyond the preview
Go deeper on NCT04604548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04604548.